Skip to content

Drug interactions

Certolizumab pegol + Pegloticase

Severity: Minor

Certolizumab pegol and Pegloticase: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pegloticase can induce anti-PEG antibodies that might bind other pegylated drugs, such as certolizumab pegol, and speed their clearance. The clinical significance is unknown, and it is largely theoretical.

What this interaction means in plain words

Certolizumab pegol and Pegloticase have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Certolizumab pegol belongs to Musculoskeletal; Pegloticase belongs to Genitourinary.

Evidence level: Low

Why it happens

Possible anti-PEG antibody cross-reactivity increasing clearance of pegylated products; not well established.

What to do

Monitor for loss of certolizumab efficacy or infusion-type reactions. No empirical dose change is recommended.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Certolizumab pegol and Pegloticase, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Certolizumab pegol with Pegloticase?

MediHelp rates the interaction as minor. Certolizumab pegol and Pegloticase have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Pegloticase can induce anti-PEG antibodies that might bind other pegylated drugs, such as certolizumab pegol, and speed their clearance. The clinical significance is unknown, and it is largely theoretical.

How serious is the interaction between Certolizumab pegol and Pegloticase?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for loss of certolizumab efficacy or infusion-type reactions. No empirical dose change is recommended.

What other medicines interact with Certolizumab pegol?

MediHelp also lists interactions of Certolizumab pegol with, for example, Adenovirus types 4 and 7 live, Bcg intravesical live, Bcg vaccine live. The full list is on the Certolizumab pegol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in